Yi Zhang

Dr. Yi Zhang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
YZYi Zhang
Yi Zhang
YZYing Zhang
Ying Zhang
XJXiao-Fei Jin
Xiao-Fei Jin
XZXiao-Hong Zhou
Xiao-Hong Zhou
XDXian-Hui Dong
Xian-Hui Dong
WGWei-Juan Gao
Wei-Juan Gao
Background: Ischemia/reperfusion (I/R) caused by ischemic stroke treatments leads to brain injury, and autophagy plays a role in the pathology. Astragaloside IV is a potential neuroprotectant, but its underlying mechanism on cerebral I/R injury needs to be explored. The objective of this study is to investigate the neuroprotective mechanism of Astragaloside IV against cerebral I/R injury. Methods: Middle cerebral artery occlusion method (MCAO) and oxygen and glucose deprivation/reoxygenation (OGD/R) method were used to simulate cerebral I/R injury in Sprague-Dawley (SD) rats and HT22 cells, respectively. The neurological score, 2,3,5-Triphe-nyltetrazolium chloride (TTC) staining, and transmission electron microscope were used to detect cerebral damage in SD rats. Cell viability and cytotoxicity assay were tested in vitro. Fluorescent staining and flow cytometry were applied to detect the level of apoptosis. Western blotting was conducted to examine the expression of proteins associated with autophagy. Results: This study found that Astragaloside IV could decrease the neurological score, reduce the infarct volume in the brain, and alleviate cerebral I/R injury in MCAO rats. Astragaloside IV promoted cell viability and balanced Bcl-2 and Bax expression in vitro, reduced the rate of apoptosis, decreased the expression of P62, and increased the expression of LC3II/LC3I in HT22 cells after OGD/R. Conclusions: These data suggested that Astragaloside IV plays a neuroprotective role by down-regulating apoptosis by promoting the degree of autophagy.

23 October 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LLLuyao Liu
Luyao Liu
RWRuikun Wang
Ruikun Wang
WGWeijuan Gao
Weijuan Gao
XHXianming Hou
Xianming Hou
XJXiaofei Jin
Xiaofei Jin
YZYi Zhang
Yi Zhang

23 November 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LLLuyao Liu
Luyao Liu
RWRuikun Wang
Ruikun Wang
WGWeijuan Gao
Weijuan Gao
XHXianming Hou
Xianming Hou
XJXiaofei Jin
Xiaofei Jin
YZYi Zhang
Yi Zhang

25 February 2026 in Brain Research
Verified
Journal Article
Closed access
CCChengxuan Chai
Chengxuan Chai
LLLuyao Liu
Luyao Liu
RWRuikun Wang
Ruikun Wang
LYLirong Yuan
Lirong Yuan
XHXianming Hou
Xianming Hou
YZYi Zhang
Yi Zhang